Denys Bondar

Denys Bondar is a Junior Research Fellow at Tallinn University of Technology's School of Science, Department of Chemistry and Biotechnology. He holds a Doctor's Degree (2023) in rational drug design, focusing on anticancer agents and antidotes for organophosphorus poisoning. His research interests include organic synthesis, nanotechnology, and nanomedicine, particularly nanoparticle-based drug delivery systems (e.g., nanodiamonds and quantum dots) targeting the central nervous system.

Education:

• Ph.D. in Chemistry (2018–2023), Tallinn University of Technology
• M.Sc. in Chemistry (2009–2011), Taras Shevchenko National University of Kyiv
• B.Sc. in Chemistry (2005–2009), Taras Shevchenko National University of Kyiv

Research Interests: Denys specializes in the design of novel therapeutic agents using nanotechnology platforms. His work emphasizes developing nanoparticle-based solutions for targeted drug delivery, particularly in combating organophosphate poisoning and cancer. Key areas include:

• Functionalization of nanodiamonds for CNS delivery
• PARP-1 inhibitors and hydroxamic acid-based reactivators
• Antimicrobial nanomaterials and surface engineering

Publications: His recent work focuses on synergistic antibacterial effects of nanoparticles, catalytic acetylcholinesterase reactivators, and nanodiamond drug coating design. Over 13 peer-reviewed articles and conference presentations highlight his contributions to nanomedicine and medicinal chemistry.

Grants & Projects:

• "Design First Responders Versatile Detection and Decontamination Methods" (NATO, 2019–2022)
• "Biodegradable formulations for antiviral coatings" (Estonian Research Council, 2020–2021)

Labs & Collaborations: Collaborates with international groups (e.g., Ghent University, CNRS Marseille) on nanotechnology and drug delivery systems. Active in conferences like the European Advanced Materials Congress and NATO-funded projects.